Nautilus Biotechnology, Inc. (NasdaqCM: NAUT)
Health Care · Life Sciences Tools & Services · US
$0.95
+5.79% today · +42.8% 1Y
Nautilus Biotechnology, Inc. (NasdaqCM: NAUT) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $121.47M and employs 127 people.
Over the last twelve months the share price has gained 42.8%, trading between 0.62 and 4.31.
Tweenvest scores Nautilus Biotechnology, Inc. across four factors: quality 30/100, value 37/100. Its strongest factor is value.
NAUT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $121.47M
- Revenue (TTM)
- $190.00K
- P/E
- —
- EPS
- -0.45
- Dividend yield
- —
- Beta (5Y)
- 0.87
- 52-week high
- $4.31
- 52-week low
- $0.62
- Avg volume (3M)
- —
- Shares outstanding
- 127.26M
- Employees
- 127
- Next earnings
- —
About Nautilus Biotechnology, Inc.
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to process labeled multi-affinity reagent binding and imaging cycles rapidly to decode and quantify the proteins present in biological samples. In addition, the company offers single-molecule library preparation kits, flow cells, affinity reagents, and instrument run buffers to perform multi-cycle analysis runs. It has a research collaboration agreement Genentech, Buck Institute, Allen Institute, Cornell University and the Qatar Foundation, and Michael J. Fox Foundation. Nautilus Biotechnology, Inc. was founded in 2016 and is headquartered in Seattle, Washington.
- Founded
- 2016
- Listed since
- Aug 7, 2020
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.67B | $629.27 | +0.27% |
| Danaher CorporationNYSE: DHR | $153.85B | $218.85 | +1.36% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $72.12B | CN¥162.86 | -3.00% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.61B | CHF592.20 | +1.09% |
| Agilent Technologies, Inc.NYSE: A | $44.91B | $159.00 | +1.73% |
| IQVIA Holdings Inc.NYSE: IQV | $42.77B | $259.82 | +1.47% |
| Waters CorporationNYSE: WAT | $40.35B | $410.70 | +1.49% |
Figures last refreshed Aug 18, 2026.